Abstract: The present invention provides for a household, agricultural, coating or personal care product composition containing the crosslinked reaction product of a network composition the reaction product of: (i) at least one anionic polymerizable ethylenically unsaturated monomer (I) selected from the group consisting of [CH2?C(R3)C(O)OXa(C2H4O)b(C3H6O)c(C4H8O)d]pP(O)(OY)q(OZ)r and CH2?C(R3)C(O)OXa?(C2H4O)b?(C3H6O)c?(C4H8O)d?—SO3—Y) where R3=H or alkyl of 1 to about 6 carbon atoms; X=alkyl, aryl, or alkaryl diradical connecting group of 0 to about 9 carbon atoms; a, a?, b, b?, c, c?, d and d? are 0 to about 100; q is 0 to about 2; r is 0 to about 2; p is 1 to about 3 subject to the limitation that p+q+r=3; and Y and Z is H, or metal ion; and (ii) one or more additional monomers (II) selected from the group consisting of acrylic acid/acrylate, methacrylic acid/methacrylate, acrylamides, vinyl acetate and styrene, which are copolymerizable with (I); and (iii) a cross-linking agent (III), capable of copolymerizin
Type:
Grant
Filed:
December 22, 2010
Date of Patent:
November 20, 2018
Assignee:
Momentive Performance Materials Inc.
Inventors:
Ning Lu, Sigfredo Gonzalez, Ernie Silvestre, Geng Wang
Abstract: The present invention provides improved pharmaceutical formulations for the treatment of Helicobacter pylori infection and duodenal ulcer disease, and includes methods of preparation and methods of medicinal use of at least one proton pump inhibitor and at least two different antibiotics within the same solid oral dosage form, whereby at least one antibiotic is coated or encapsulated independently from at least one other antibiotic within this solid oral dosage form.